Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

(2012) Jeong Eun Kim et al.   ONCOLOGY

Complete response for advanced liver cancer during sorafenib therapy: Case Report

(2011) Rodolfo Sacco et al.   BMC GASTROENTEROLOGY

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

(2011) Massimo Iavarone et al.   HEPATOLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib

(2011) Giovanni Abbadessa   WORLD JOURNAL OF GASTROENTEROLOGY

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

(2010) R. Lencioni et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

From Randomized Controlled Trials to Observational Studies

(2009) Stuart L. Silverman   AMERICAN JOURNAL OF MEDICINE

Sorafenib

(2009) Gillian M. Keating et al.   DRUGS

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

(2008) Shenhong Wu et al.   LANCET ONCOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE